Indian Digital healthcare platform Pharm Easy became the latest startup business in our country and listed in domestic market. Pharm Easy provide health service ranging from tele-communication to radiology test and provide home delivery of medical products. When we compare the past 3months sales of the company, now the monitary value of sales of the company stood at 30.26 billion Rupees. Pharmacy’s company may consider a private issuance of shares worth up to 12.50 billion rupees. Naspers, a technology-focused investor, as well as organizations connected with global investment group CDPQ and private equity firm TPG, are among the company's investors. The company acquired thyrocare technologies, India's leading diagnostic test provider, in order to diversify its operations. The IPO filing for pharmeasy comes on the same day as Nykaa, an Indian fashion e-commerce firm, is scheduled to debut on the stock exchange, and Paytm, a finance...